Christopher R. Stone

Array ( [id] => 11025067 [patent_doc_number] => 20160222020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'NOVEL TRICYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/017802 [patent_app_country] => US [patent_app_date] => 2016-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 236400 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10805119 [patent_doc_number] => 20160151276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'PREVENTION OF HIV-INFECTION' [patent_app_type] => utility [patent_app_number] => 15/017168 [patent_app_country] => US [patent_app_date] => 2016-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6531 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15017168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11053392 [patent_doc_number] => 20160250354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'METHODS AND COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 15/010747 [patent_app_country] => US [patent_app_date] => 2016-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 40545 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15010747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11335532 [patent_doc_number] => 20160361287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P450' [patent_app_type] => utility [patent_app_number] => 14/992534 [patent_app_country] => US [patent_app_date] => 2016-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18898 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10754932 [patent_doc_number] => 20160101084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'METHODS OF TREATING DEGENERATIVE DISEASES/INJURIES' [patent_app_type] => utility [patent_app_number] => 14/975975 [patent_app_country] => US [patent_app_date] => 2015-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12444 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14975975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11330906 [patent_doc_number] => 09522137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy' [patent_app_type] => utility [patent_app_number] => 14/972269 [patent_app_country] => US [patent_app_date] => 2015-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21968 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 364 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14972269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11217722 [patent_doc_number] => 09446041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Method of treatment' [patent_app_type] => utility [patent_app_number] => 14/953546 [patent_app_country] => US [patent_app_date] => 2015-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 109813 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14953546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10721051 [patent_doc_number] => 20160067198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'HALOGENATED ALIPHATIC CARBOXYLIC ACIDS, OLIGOMERS AND/OR POLYMERS THEREOF AND THEIR USE IN DEVITALIZING EXTERNAL AND INTERNAL NEOPLASMS' [patent_app_type] => utility [patent_app_number] => 14/945616 [patent_app_country] => US [patent_app_date] => 2015-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22994 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14945616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11625854 [patent_doc_number] => 20170136044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'METHOD OF TREATING PRE-CANCEROUS LESIONS WITH GLYPHOSATE, AND COMPOSITIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/939968 [patent_app_country] => US [patent_app_date] => 2015-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2711 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14939968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059594 [patent_doc_number] => 20160256557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'INJECTABLE PHARMACEUTICAL COMPOSITIONS OF AN ANTHRACENEDIONE DERIVATIVE WITH ANTI-TUMORAL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/937689 [patent_app_country] => US [patent_app_date] => 2015-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1613 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12366921 [patent_doc_number] => 09957173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Treatment of water [patent_app_type] => utility [patent_app_number] => 14/878240 [patent_app_country] => US [patent_app_date] => 2015-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11968 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14878240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10705381 [patent_doc_number] => 20160051528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'Method for the Treatment of Pompe Disease Using 1-Deoxynojirimycin Derivatives' [patent_app_type] => utility [patent_app_number] => 14/876018 [patent_app_country] => US [patent_app_date] => 2015-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23238 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662200 [patent_doc_number] => 20160008344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'METHODS FOR THE TREATMENT OF NON-HODGKIN\'S LYMPHOMAS USING LENALIDOMIDE, AND GENE AND PROTEIN BIOMARKERS AS A PREDICTOR' [patent_app_type] => utility [patent_app_number] => 14/858594 [patent_app_country] => US [patent_app_date] => 2015-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20688 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14858594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11059451 [patent_doc_number] => 20160256413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-08 [patent_title] => 'COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISEASE' [patent_app_type] => utility [patent_app_number] => 14/856398 [patent_app_country] => US [patent_app_date] => 2015-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11395 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14856398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10721028 [patent_doc_number] => 20160067175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'INTRATHECAL MULTIDRUG INFUSION FOR PAIN CONTROL' [patent_app_type] => utility [patent_app_number] => 14/845546 [patent_app_country] => US [patent_app_date] => 2015-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5042 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14845546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10691627 [patent_doc_number] => 20160037774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'SYNERGISTIC FUNGICIDAL MIXTURES FOR FUNGAL CONTROL IN CEREALS' [patent_app_type] => utility [patent_app_number] => 14/818945 [patent_app_country] => US [patent_app_date] => 2015-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4675 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14818945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10676484 [patent_doc_number] => 20160022629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'Sublingual Spray Formulation Comprising Dihydroartemesinin' [patent_app_type] => utility [patent_app_number] => 14/813424 [patent_app_country] => US [patent_app_date] => 2015-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7928 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14813424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10820367 [patent_doc_number] => 20160166531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/800128 [patent_app_country] => US [patent_app_date] => 2015-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6762 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14800128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10428863 [patent_doc_number] => 20150313873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/795709 [patent_app_country] => US [patent_app_date] => 2015-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14419 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14795709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405118 [patent_doc_number] => 20150290127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'TRANEXAMIC ACID FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/745255 [patent_app_country] => US [patent_app_date] => 2015-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32330 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14745255 [rel_patent_id] =>[rel_patent_doc_number] =>)